|Post IPO Valuation|
|Life Technologies, 2/2014||$13.6B|
|One Lambda, 7/2012|
|Doe & Ingalls, 5/2012||$175M|
|TREK Diagnostic Systems, 7/2011|
|Ahura Scientific, 1/2010||$145M|
|ABR--Affinity BioReagents, 7/2008|
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.